Ingenious Medtech Private Limited - Due diligence report

A 360° intelligence report on Ingenious Medtech Private Limited: trust score, financial health, credit view, compliance, directors, growth a…

2016-12-01 Thane, Maharashtra Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ingenious Medtech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
73/100
Trust Score
Moderate

Ingenious Medtech Private Limited is assessed as Moderate with a Trust Score of 73/100. Ingenious Medtech Private Limited is an active private limited indian non-government company incorporated in 2016, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 26 Oct 2026 from the latest processed filings. Ingenious Medtech Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
73/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
45/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
PAVEL BOHDAL 01234567 Director 01/04/2018 6 yrs Approved
SNEHA SHANTANU MAYEKAR 01234567 Director 01/04/2018 6 yrs Approved
SHANTANU SUBHASH MAYEKAR 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
7 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 60
Growth signals & trust indicators
Steady revenue growth: +38% over 4 year(s).
Operating for 9 years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence75/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view58/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
10 May 2018
Securities allotted
512546 Preference Shares - 51.25 Lakh raised
01 Nov 2017
Securities allotted
140546 Preference Shares - 14.05 Lakh raised
29 Sep 2017
Director ceased
PAVEL BOHDAL
04 Sep 2017
Securities allotted
68022 Preference Shares - 6.80 Lakh raised
31 May 2017
Securities allotted
134720 Preference Shares - 13.47 Lakh raised
18 Mar 2017
Securities allotted
10000 Equity Shares - 1.00 Lakh raised
Securities allotted
63356 Preference Shares - 6.34 Lakh raised
27 Jan 2017
Director appointed
PAVEL BOHDAL (Director)
01 Dec 2016
Incorporated
Registered with Roc Mumbai
Director appointed
SNEHA SHANTANU MAYEKAR (Director)
Director appointed
SHANTANU SUBHASH MAYEKAR (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 7 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Immuno Natural Oils Private Limited U15140MP1982PTC002031 Mandsaur, Madhya Pradesh, India
Pragya Trademart Private Limited U51909BR2014PTC022422 Gadharganj, Bihar, India
Kavita Agencies Private Limited U00064BR2000PTC009351 P.S.-Police Station, Bihar, India
Handa Float Glass Private Limited U74999HR2010PTC040599 Karnal, Haryana, India
Narang Lites Private Limited U51909DL2017PTC322423 New Delhi, Delhi, India
Next Packaging Machinery Private Limited U29308MH2020PTC341662 Mumbai, Maharashtra, India
Kalinga Panels Private Limited U32204KA2010PTC052798 Bangalore North, Karnataka, India
Transmonk India Private Limited U74999PN2016PTC166351 Khed, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ingenious Medtech Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ingenious Medtech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Ingenious Medtech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 73/100, distress signals and MSME payment-delay disclosures - know whether Ingenious Medtech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Ingenious Medtech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ingenious Medtech Private Limited an active company?

Ingenious Medtech Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Ingenious Medtech Private Limited financially healthy?

Ingenious Medtech Private Limited has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Ingenious Medtech Private Limited?

Its overall Trust Score is 73/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ingenious Medtech Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Ingenious Medtech Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Ingenious Medtech Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Ingenious Medtech Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.